AGIO - Bathi sadurunge bunga, pajak, lan amortisasi Agios
Agios Pharmaceuticals (AGIO) is undergoing a shift in product focus toward rare blood pathologies, ignoring macroeconomic trends. Operating cash flow before interest and taxes demonstrates a pricing vector, where 0.00 captures the magnitude of this parameter. Growth is driven by the expanded application of Pyrukynd, royalties, and cash for M&A transactions. Innovations in cellular metabolism enable the activation of enzymes for the treatment of anemias.
Ringkesan rincian data analitis Agios Pharmaceuticals, Inc. (AGIO)
- kuotasi saiki lan rata-rata prakiraan nilai:
- statistik kapitalisasi pasar:
- data kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Agios Pharmaceuticals|AGIO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Agios|AGIO - Utang perusahaan|Rasio utang marang kapitalisasi buku Agios Pharmaceuticals|AGIO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Agios Pharmaceuticals|Koefisien jangkoan perantara agios.com
- rincian asil keuangan lan kelipatan valuasi:
AGIO - Bathi resik perusahaan|Bathi mangsa ngarep Agios Pharmaceuticals|AGIO - Pangali P/E|Pangali Forward P/E agios.com|AGIO - Pangali PEG|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Agios Pharmaceuticals|AGIO - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Agios Pharmaceuticals|AGIO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan agios.com|AGIO - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Agios Pharmaceuticals
Analisis kabeh metrik perusahaan:Agios Corp (AGIO)
This indicator captures net cash flow from operating activities before interest and taxes, allowing for an assessment of the business's actual ability to generate value amid high borrowing costs. By analyzing the volume of operating cash flow, an investor can see the impact of royalties and the expansion of Pyrukynd on liquidity, which determines the potential for Agios Pharmaceuticals (AGIO) to execute strategic M&A deals.
Karo sapa Agios Pharmaceuticals saingan
ASND - Bathi operasional sadurunge ngurangi amortisasi|Madrigal Pharmaceuticals - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|AKRO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MTSR (Metsera Corp) - Bathi operasional EBITDA|Bathi operasional EBITDA MoonLake Corp|Bathi operasional EBITDA CRNX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAMS (newamsterdampharma.com)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Bathi sadurunge bunga, pajak, lan amortisasi|ETNB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GPCR: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MDXG: Bathi operasional EBITDA|RZLT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Altimmune Corp (ALT)|Bathi operasional sadurunge ngurangi amortisasi Aardvark Pharma AARD|Bathi operasional EBITDA SGMT (Sagimet Biosciences)|Bathi operasional EBITDA bioagelabs.com BIOA|Biomea Fusion - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Quince Therapeutics (QNCX)|GUTS: Bathi operasional EBITDA|VTVT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Agape ATP Corp|Bathi sadurunge bunga, pajak, lan amortisasi Pluri Inc PLUR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Synlogic, Inc. (SYBX)|Pendapatan operasional sadurunge ngurangi amortisasi Lipocine Inc|Matinas BioPharma Holdings - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SPRB|GLTO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi CTCX|LUMO: Bathi operasional EBITDA|Organovo Holdings - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RDUS (Radius Health) - Bathi operasional EBITDA
